Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 05 2020
Historique:
received: 26 11 2019
accepted: 16 04 2020
entrez: 10 5 2020
pubmed: 10 5 2020
medline: 18 8 2020
Statut: epublish

Résumé

The prefusion conformation of HIV-1 envelope protein (Env) is recognized by most broadly neutralizing antibodies (bnAbs). Studies showed that alterations of its membrane-related components, including the transmembrane domain (TMD) and cytoplasmic tail (CT), can reshape the antigenic structure of the Env ectodomain. Using nuclear magnetic resonance (NMR) spectroscopy, we determine the structure of an Env segment encompassing the TMD and a large portion of the CT in bicelles. The structure reveals that the CT folds into amphipathic helices that wrap around the C-terminal end of the TMD, thereby forming a support baseplate for the rest of Env. NMR dynamics measurements provide evidences of dynamic coupling across the TMD between the ectodomain and CT. Pseudovirus-based neutralization assays suggest that CT-TMD interaction preferentially affects antigenic structure near the apex of the Env trimer. These results explain why the CT can modulate the Env antigenic properties and may facilitate HIV-1 Env-based vaccine design.

Identifiants

pubmed: 32385256
doi: 10.1038/s41467-020-16165-0
pii: 10.1038/s41467-020-16165-0
pmc: PMC7210310
doi:

Substances chimiques

Antibodies, Neutralizing 0
HIV Antibodies 0
env Gene Products, Human Immunodeficiency Virus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2317

Subventions

Organisme : NIGMS NIH HHS
ID : P41 GM132079
Pays : United States
Organisme : NIBIB NIH HHS
ID : P41 EB002026
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI127193
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI147884
Pays : United States
Organisme : NIH HHS
ID : S10 OD023513
Pays : United States

Références

Harrison, S. C. Mechanism of membrane fusion by viral envelope proteins. Adv. Virus Res. 64, 231–259 (2005).
pubmed: 16139596 pmcid: 7173036
Chen B. Molecular mechanism of HIV-1 entry. Trends Microbiol. 27, 878–891 (2019).
Chan, D. C., Fass, D., Berger, J. M. & Kim, P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263–273 (1997).
pubmed: 9108481
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J. & Wiley, D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426–430 (1997).
pubmed: 9163431
Chen, J. et al. HIV-1 ENVELOPE. Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein. Science 349, 191–195 (2015).
pubmed: 26113642 pmcid: 4701381
Kovacs, J. M. et al. HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120. Proc. Natl Acad. Sci. USA 109, 12111–12116 (2012).
pubmed: 22773820
Sanders, R. W. et al. A next-generation cleaved, soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog. 9, e1003618 (2013).
pubmed: 24068931 pmcid: 3777863
Dev, J. et al. Structural basis for membrane anchoring of HIV-1 envelope spike. Science 353, 172–175 (2016).
pubmed: 27338706 pmcid: 5085267
Fu, Q. et al. Structure of the membrane proximal external region of HIV-1 envelope glycoprotein. Proc. Natl Acad. Sci. USA 115, E8892–E8899 (2018).
pubmed: 30185554
Liu, J., Bartesaghi, A., Borgnia, M. J., Sapiro, G. & Subramaniam, S. Molecular architecture of native HIV-1 gp120 trimers. Nature 455, 109–113 (2008).
pubmed: 18668044 pmcid: 2610422
Julien, J. P. et al. Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science 342, 1477–1483 (2013).
pubmed: 24179159
Lyumkis, D. et al. Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science 342, 1484–1490 (2013).
pubmed: 24179160 pmcid: 3954647
Pancera, M. et al. Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature 514, 455–461 (2014).
pubmed: 25296255 pmcid: 4348022
Lee, J. H., Ozorowski, G. & Ward, A. B. Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer. Science 351, 1043–1048 (2016).
pubmed: 26941313 pmcid: 5001164
Pan, J., Peng, H., Chen, B. & Harrison, S. C. Cryo-EM structure of full-length HIV-1 Env bound with the fab of antibody PG16. J. Mol. Biol. 14, 1158–1168 (2020).
Torrents de la Pena, A. et al. Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics. PLoS Pathog. 15, e1007920 (2019).
pubmed: 31306470 pmcid: 6658011
Postler, T. S. & Desrosiers, R. C. The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. J. Virol. 87, 2–15 (2013).
pubmed: 23077317 pmcid: 3536369
Santos da Silva, E., Mulinge, M. & Perez Bercoff, D. The frantic play of the concealed HIV envelope cytoplasmic tail. Retrovirology 10, 54 (2013).
pubmed: 23705972
Murphy, R. E., Samal, A. B., Vlach, J. & Saad, J. S. Solution Structure and Membrane Interaction of the Cytoplasmic Tail of HIV-1 gp41 Protein. Structure 25, 1708–1718 e1705 (2017).
pubmed: 29056482 pmcid: 5687296
Chou, J. J., Kaufman, J. D., Stahl, S. J., Wingfield, P. T. & Bax, A. Micelle-induced curvature in a water-insoluble HIV-1 Env peptide revealed by NMR dipolar coupling measurement in stretched polyacrylamide gel. J. Am. Chem. Soc. 124, 2450–2451 (2002).
pubmed: 11890789
Edwards, T. G. et al. Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein. J. Virol. 76, 2683–2691 (2002).
pubmed: 11861835 pmcid: 135967
Durham, N. D. et al. Neutralization resistance of virological synapse-mediated HIV-1 Infection is regulated by the gp41 cytoplasmic tail. J. Virol. 86, 7484–7495 (2012).
pubmed: 22553332 pmcid: 3416307
Fu Q., Piai A., Chen W., Xia K. & Chou J. J. Structure determination protocol for transmembrane domain oligomers. Nat. Protoc. 14, 2483–2520 (2019).
Xu, C. et al. Regulation of T cell receptor activation by dynamic membrane binding of the CD3ɛ cytoplasmic tyrosine-based motif. Cell 135, 702–713 (2008).
pubmed: 19013279 pmcid: 2597348
Piai, A., Fu, Q., Dev, J. & Chou, J. J. Optimal bicelle size q for solution NMR studies of the protein transmembrane partition. Chemistry 23, 1361–1367 (2017).
pubmed: 27747952
Piai, A., Dev, J., Fu, Q. & Chou, J. J. Stability and water accessibility of the trimeric membrane anchors of the HIV-1 envelope spikes. J. Am. Chem. Soc. 139, 18432–18435 (2017).
pubmed: 29193965 pmcid: 5831154
Chen, W., Dev, J., Mezhyrova, J., Pan, L., Piai, A. & Chou, J. J. The unusual transmembrane partition of the hexameric channel of the hepatitis C virus. Structure 26, 627–634 e624 (2018).
pubmed: 29551287 pmcid: 5884736
Julien, J. P. et al. Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9. Proc. Natl Acad. Sci. USA 110, 4351–4356 (2013).
pubmed: 23426631
Lee, J. H. et al. A broadly neutralizing antibody targets the dynamic HIV envelope trimer apex via a long, rigidified, and anionic beta-hairpin structure. Immunity 46, 690–702 (2017).
pubmed: 28423342 pmcid: 5400778
Pancera, M. et al. Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16. Nat. Struct. Mol. Biol. 20, 804 (2013).
Sarzotti-Kelsoe, M. et al. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. J. Immunol. Methods 409, 131–146 (2014).
pubmed: 24291345
Scheid, J. F. et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333, 1633–1637 (2011).
pubmed: 21764753 pmcid: 3351836
Walker, L. M. et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326, 285–289 (2009).
pubmed: 19729618 pmcid: 3335270
Walker, L. M. et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477, 466–470 (2011).
pubmed: 21849977 pmcid: 3393110
Swetnam, J., Shmelkov, E., Zolla-Pazner, S. & Cardozo, T. Comparative magnitude of cross-strain conservation of HIV variable loop neutralization epitopes. PLoS ONE 5, e15994 (2010).
pubmed: 21209919 pmcid: 3012121
Thali, M. et al. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67, 3978–3988 (1993).
pubmed: 7685405 pmcid: 237765
Han, Q. et al. Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations. Nat. Commun. 10, 2898 (2019).
pubmed: 31263112 pmcid: 6602974
Zhu, P. et al. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441, 847–852 (2006).
pubmed: 16728975
Postler, T. S. & Desrosiers, R. C. The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. J. Virol. 87, 2–15 (2013).
pubmed: 23077317 pmcid: 3536369
Wang, H., Cohen, A. A., Galimidi, R. P., Gristick, H. B., Jensen, G. J. & Bjorkman, P. J. Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop. Proc. Natl Acad. Sci. USA 113, E7151–E7158 (2016).
pubmed: 27799557
Ozorowski, G. et al. Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike. Nature 547, 360–363 (2017).
pubmed: 28700571 pmcid: 5538736
Seaman, M. S. et al. Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J. Virol. 84, 1439–1452 (2010).
pubmed: 19939925
Kneller, J. M., Lu, M. & Bracken, C. An effective method for the discrimination of motional anisotropy and chemical exchange. J. Am. Chem. Soc. 124, 1852–1853 (2002).
pubmed: 11866588
Evans, D. T., Tillman, K. C. & Desrosiers, R. C. Envelope glycoprotein cytoplasmic domains from diverse lentiviruses interact with the prenylated Rab acceptor. J. Virol. 76, 327–337 (2002).
pubmed: 11739697 pmcid: 135700
Wyma, D. J. et al. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J. Virol. 78, 3429–3435 (2004).
pubmed: 15016865 pmcid: 371074
Hill, C. P., Worthylake, D., Bancroft, D. P., Christensen, A. M. & Sundquist, W. I. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl Acad. Sci. USA 93, 3099–3104 (1996).
pubmed: 8610175
Alfadhli, A., Barklis, R. L. & Barklis, E. HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate. Virology 387, 466–472 (2009).
pubmed: 19327811 pmcid: 2680355
Kovacs, J. M. et al. HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120. Proc. Natl Acad. Sci. USA 109, 12111–12116 (2012).
pubmed: 22773820
Sanders, R. W. et al. A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog. 9, e1003618 (2013).
pubmed: 24068931 pmcid: 3777863
Ma, X. et al. HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations. eLife 7, e34271 (2018).
Lu, M. et al. Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET. Nature 568, 415–419 (2019).
pubmed: 30971821 pmcid: 6655592
Stadtmueller, B. M. et al. DEER spectroscopy measurements reveal multiple conformations of HIV-1 SOSIP envelopes that show similarities with envelopes on native virions. Immunity 49, 235–246 e234 (2018).
pubmed: 30076100 pmcid: 6104740
Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J. & Bax, A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995).
Bartels, C., Xia, T. H., Billeter, M., Guntert, P. & Wuthrich, K. The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 6, 1–10 (1995).
pubmed: 22911575
Salzmann, M., Wider, G., Pervushin, K. & Wuthrich, K. Improved sensitivity and coherence selection for [15N,1H]-TROSY elements in triple resonance experiments. J. Biomol. NMR 15, 181–184 (1999).
pubmed: 10605091
Kay, L. E., Ikura, M., Tschudin, R. & Bax, A. Three-dimensional triple resonance NMR spectroscopy of isotopically enriched proteins. J. Magn. Reson 89, 496–514 (1990).
Barbato, G., Ikura, M., Kay, L. E., Pastor, R. W. & Bax, A. Backbone dynamics of calmodulin studied by 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible. Biochemistry 31, 5269–5278 (1992).
pubmed: 1606151
Schwieters, C. D., Kuszewski, J. J., Tjandra, N. & Clore, G. M. The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 160, 65–73 (2003).
pubmed: 12565051
Shen, Y., Delaglio, F., Cornilescu, G. & Bax, A. TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J. biomolecular NMR 44, 213–223 (2009).
Li, M. et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79, 10108–10125 (2005).
pubmed: 16051804 pmcid: 1182643
Gristick, H. B. et al. Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site. Nat. Struct. Mol. Biol. 23, 906–915 (2016).
pubmed: 27617431 pmcid: 5127623

Auteurs

Alessandro Piai (A)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, MA, 02115, USA.

Qingshan Fu (Q)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, MA, 02115, USA.

Yongfei Cai (Y)

Division of Molecular Medicine, Boston Children's Hospital, Boston, MA, 02115, USA.
Department of Pediatrics, Harvard Medical School, 3 Blackfan Street, Boston, MA, 02115, USA.

Fadi Ghantous (F)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA.

Tianshu Xiao (T)

Division of Molecular Medicine, Boston Children's Hospital, Boston, MA, 02115, USA.
Department of Pediatrics, Harvard Medical School, 3 Blackfan Street, Boston, MA, 02115, USA.

Md Munan Shaik (MM)

Division of Molecular Medicine, Boston Children's Hospital, Boston, MA, 02115, USA.
Department of Pediatrics, Harvard Medical School, 3 Blackfan Street, Boston, MA, 02115, USA.

Hanqin Peng (H)

Division of Molecular Medicine, Boston Children's Hospital, Boston, MA, 02115, USA.

Sophia Rits-Volloch (S)

Division of Molecular Medicine, Boston Children's Hospital, Boston, MA, 02115, USA.

Wen Chen (W)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, MA, 02115, USA.

Michael S Seaman (MS)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA.

Bing Chen (B)

Division of Molecular Medicine, Boston Children's Hospital, Boston, MA, 02115, USA. bchen@crystal.harvard.edu.
Department of Pediatrics, Harvard Medical School, 3 Blackfan Street, Boston, MA, 02115, USA. bchen@crystal.harvard.edu.

James J Chou (JJ)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, MA, 02115, USA. james_chou@hms.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH